Doctors know this happens to GLP-1 patients, but the cause and scale of the changes is still being investigated
Disclaimer: Copyright by CMEducation Resources, LLC All rights reserved
[DOI] [PMC free article] [PubMed] [Google Scholar] 30.Yu B., Russanova V.R., Gravina S., Hartley S., Mullikin J.C., Ignezweski A., Graham J., Segars J.H., De Cherney A.H., Howard B.H
Youssef JG, Zahiruddin F, Youssef G et al (2021) G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg
Mycophenolate mofetil is recommended as the preferred second-line therapy by both the American Association for the Study of Liver Diseases (AASLD) and ESPGHAN [29, 42]
Patients typically undergo 2 to 4 sessions , spaced several weeks apart, and begin seeing noticeable results within 6 to 8 weeks after treatment